Skip to content

The effect of simultaneous injection of propofol and epinephrine in anesthesia.

The effect of combined low-dose Epinephrine and Propofol infusion on Hemodynamic statues and Anesthesia-related complication: A Randomized Clinical Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251005067513N1
Enrollment
60
Registered
2026-05-16
Start date
2026-03-21
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia.

Interventions

Intervention 1: Intervention group: General anesthesia with epinephrine: After induction of anesthesia by the anesthesiologist, a 1:10,000 dilution of epinephrine at a dose of 50 micrograms will be in

Sponsors

Shahre-kord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Age 18 to 45 years 2. ASA class I and II (except for hypertension and cardiac disease) 3. Written consent to participate in the study

Exclusion criteria

Exclusion criteria: People with coagulation disorders, heart disease, hypertension, cerebrovascular disease, peripheral vascular disease, or drug allergies Patient unwillingness to continue participation in the study or failure to sign the informed consent form. Alcohol and caffeine consumption Detection of any severe hemodynamic instability or unexpected need for emergency intervention during initial monitoring/assessment. Unexpected findings on baseline laboratory tests (if performed) that constitute a contraindication to the intervention. Inability to ensure standard conditions for baseline measurements (e.g., severe uncooperativeness).

Design outcomes

Primary

MeasureTime frame
Mean heart rate (beats per minute) at four time points: before induction (T0), one minute post-induction (T1), three minutes post-induction (T2), and at the end of surgery (T3). Timepoint: Before induction (T0), one minute post-induction (T1), three minutes post-induction (T2), and at the end of surgery (T3). Method of measurement: Same pulse oximetry.;Determining and comparing the mean blood pressure score of patients undergoing surgery under general anesthesia with propofol before, immediately, and after the intervention in the two intervention and control groups, within and between groups. Timepoint: Before induction (T0), one minute post-induction (T1), three minutes post-induction (T2), end of surgery (T3). Method of measurement: Cuffs of the same size arm in the same place for the same people.;Mean arterial oxygen saturation percentage (SpO2) at four time points: before induction (T0), one minute post-induction (T1), three minutes post-induction (T2), and at the end of surgery (T3). Timepoint: Before induction (T0), one minute post-induction (T1), three minutes post-induction (T2), end of surgery (T3). Method of measurement: Same Pulse oximetry.;Mean respiratory rate (breaths per minute) at four time points: before induction (T0), one minute post-induction (T1), three minutes post-induction (T2), and at the end of surgery (T3). Timepoint: Before induction (T0), one minute post-induction (T1), three minutes post-induction (T2), end of surgery (T3). Method of measurement: Counting the number of breaths per minute.;Occurrence of any electrocardiogram rhythm or morphology changes including ventricular tachycardia, bradycardia requiring treatment, ventricular or atrial extrasystoles, and ST segment changes during anesthesia until the end of recovery. Timepoint: Continuously from before induction (T0) until the end of recovery (up to 2 hours after surgery), recording any clinically significant change. Method of measurement: ECG.;Frequency of the following adverse ev

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad javad Torkan

Shahre-kord University of Medical Sciences

drmjt1372@gmail.com+98 31 3651 9630

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026